---
created: '2026-02-09T08:04:40.926697Z'
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/organ/precuneus/
slug: precuneus
tags:
- organ
templateEngineOverride: njk
title: Precuneus
type: organ
updated: '2026-02-09T08:04:40.926697Z'
---

{% raw %}
<h1>Precuneus</h1>
<h2>Overview (Consumer-Friendly)</h2>
<p>Your precuneus is located at the top-back part of your brain (upper portion of the parietal lobe) and is part of your brain's &quot;default mode network.&quot; Think of it as your brain's &quot;mental time machine and self-reflection center&quot; - it helps you remember past experiences, imagine future scenarios, create mental images, and think about yourself. It's also involved in your sense of consciousness and self-awareness.</p>
<h3>Key Functions</h3>
<ul>
<li>Retrieving personal memories from your past</li>
<li>Imagining and visualizing future scenarios</li>
<li>Creating vivid mental images</li>
<li>Self-referential thinking and self-consciousness</li>
<li>Visuospatial processing and navigation</li>
<li>Integrating sensory information from your body</li>
</ul>
<h3>Lifestyle Tips for Precuneus Health</h3>
<ul>
<li><strong>Practice visualization exercises</strong> - Strengthens mental imagery</li>
<li><strong>Engage in autobiographical memory recall</strong> - Exercises episodic memory circuits</li>
<li><strong>Mindfulness meditation</strong> - Balances DMN activity, reduces excessive rumination</li>
<li><strong>Spatial navigation activities</strong> - Maps, orienteering, spatial puzzles</li>
<li><strong>Quality sleep</strong> - Memory consolidation depends on precuneus function</li>
<li><strong>Stay mentally active</strong> - Cognitive engagement maintains precuneus health</li>
</ul>
<h2>Clinical Information (Medical Professional)</h2>
<h3>Neuroanatomy</h3>
<p>The precuneus is located on the medial surface of the superior parietal lobule, posterior to the marginal branch of the cingulate sulcus and anterior to the parieto-occipital sulcus. It is one of the most metabolically active brain regions and a critical hub of the default mode network.</p>
<p><strong>Anatomical Features:</strong></p>
<ul>
<li><strong>Location</strong>: Medial parietal cortex, Brodmann area 7</li>
<li><strong>Connections</strong>: Extensively connected to other DMN regions and sensory-motor cortices</li>
<li><strong>High metabolic rate</strong>: One of the highest baseline glucose consumption rates</li>
<li><strong>Vulnerable region</strong>: Early amyloid deposition in Alzheimer's disease</li>
</ul>
<p><strong>Functional Subdivisions:</strong></p>
<ul>
<li><strong>Anterior Precuneus</strong>: Motor imagery, self-referential processing
<ul>
<li>Stronger connections with motor cortex, cingulate motor area</li>
</ul>
</li>
<li><strong>Central Precuneus</strong>: Episodic memory, visuospatial processing
<ul>
<li>Strongest connections with hippocampus, posterior cingulate cortex</li>
</ul>
</li>
<li><strong>Posterior Precuneus</strong>: Visual-spatial integration
<ul>
<li>Connections with occipital cortex, visual association areas</li>
</ul>
</li>
</ul>
<p><strong>Default Mode Network Role:</strong><br />
Core hub alongside posterior cingulate cortex, critical for:</p>
<ul>
<li>Self-referential mental activity</li>
<li>Episodic memory (past and future)</li>
<li>Theory of mind (understanding others' mental states)</li>
<li>Mental imagery and visualization</li>
<li>Consciousness and sense of self</li>
</ul>
<h3>Cytoarchitecture</h3>
<ul>
<li><strong>Association cortex</strong>: Six-layered neocortex with rich associative connections</li>
<li><strong>Large pyramidal neurons</strong>: Extensive dendritic arbors in layers II/III and V</li>
<li><strong>High synaptic density</strong>: Particularly in memory-related circuits</li>
<li><strong>Dense cholinergic innervation</strong>: From basal forebrain (memory function)</li>
<li><strong>Rich blood supply</strong>: High metabolic demands require extensive vascularization</li>
</ul>
<h3>Common Pathologies</h3>
<ul>
<li><strong>Alzheimer's Disease</strong>: Early amyloid-beta and tau deposition
<ul>
<li>Hypometabolism on FDG-PET (preclinical AD marker)</li>
<li>Disrupted DMN connectivity</li>
<li>Episodic memory deficits</li>
</ul>
</li>
<li><strong>Autism Spectrum Disorders</strong>: Reduced precuneus activation during self-referential tasks
<ul>
<li>Impaired theory of mind and social cognition</li>
</ul>
</li>
<li><strong>Schizophrenia</strong>: DMN dysfunction, impaired self-referential processing
<ul>
<li>Hallucinations may involve precuneus hyperactivity</li>
</ul>
</li>
<li><strong>Depression</strong>: Excessive rumination, precuneus hyperactivity
<ul>
<li>Failure to deactivate during tasks</li>
</ul>
</li>
<li><strong>ADHD</strong>: Reduced precuneus-DMN connectivity, mind-wandering</li>
<li><strong>Stroke</strong>: Right precuneus lesions cause hemispatial neglect, spatial deficits</li>
</ul>
<h3>Clinical Assessment</h3>
<ul>
<li><strong>Resting-State fMRI</strong>: Default mode network functional connectivity
<ul>
<li>Precuneus-PCC connectivity (core DMN)</li>
<li>DMN vs. task-positive network balance</li>
</ul>
</li>
<li><strong>Task-based fMRI</strong>:
<ul>
<li>Episodic memory retrieval (autobiographical memory)</li>
<li>Mental imagery tasks (visual, spatial)</li>
<li>Theory of mind and self-referential judgments</li>
</ul>
</li>
<li><strong>PET Imaging</strong>:
<ul>
<li>FDG-PET: Glucose metabolism (hypometabolism in AD, MCI)</li>
<li>Amyloid PET: Early plaque deposition (preclinical AD)</li>
<li>Tau PET: Neurofibrillary tangle burden</li>
</ul>
</li>
<li><strong>Neuropsychological Testing</strong>: Episodic memory, visuospatial function, imagery</li>
</ul>
<h3>Differential Diagnosis</h3>
<ul>
<li>Alzheimer's disease vs. Lewy body dementia vs. frontotemporal dementia</li>
<li>Autism vs. schizoid personality disorder vs. schizophrenia</li>
<li>Major depression vs. persistent depressive disorder</li>
<li>ADHD vs. daydreaming/mind-wandering vs. absence epilepsy</li>
</ul>
<h2>Research Data (Research-Focused)</h2>
<h3>Neurotransmitter Receptors</h3>
<table>
<thead>
<tr>
<th>Receptor</th>
<th>Neurotransmitter</th>
<th>Density</th>
<th>Functional Role</th>
</tr>
</thead>
<tbody>
<tr>
<td>NMDA</td>
<td>Glutamate</td>
<td>High</td>
<td>Synaptic plasticity, memory encoding/retrieval</td>
</tr>
<tr>
<td>AMPA</td>
<td>Glutamate</td>
<td>High</td>
<td>Fast excitatory transmission</td>
</tr>
<tr>
<td>GABA_A</td>
<td>GABA</td>
<td>High</td>
<td>Inhibitory modulation, DMN regulation</td>
</tr>
<tr>
<td>M1 mAChR</td>
<td>Acetylcholine</td>
<td>High</td>
<td>Memory retrieval, attention</td>
</tr>
<tr>
<td>nAChR (α4β2)</td>
<td>Acetylcholine</td>
<td>Medium</td>
<td>Cognitive enhancement, memory</td>
</tr>
<tr>
<td>5-HT1A</td>
<td>Serotonin</td>
<td>Medium</td>
<td>Mood regulation, DMN modulation</td>
</tr>
<tr>
<td>D1/D2</td>
<td>Dopamine</td>
<td>Medium</td>
<td>Reward-related memory, imagery</td>
</tr>
</tbody>
</table>
<h3>Structural Connectivity</h3>
<p><strong>Afferent Connections:</strong></p>
<ul>
<li>Posterior cingulate cortex (DMN hub) - 100% strength</li>
<li>Hippocampus (episodic memory) - 95% strength</li>
<li>Medial prefrontal cortex (self-referential) - 90% strength</li>
<li>Angular gyrus (semantic, spatial) - 95% strength</li>
<li>Visual cortex (imagery) - 85% strength</li>
<li>Parietal cortex (sensorimotor integration) - 90% strength</li>
</ul>
<p><strong>Efferent Connections:</strong></p>
<ul>
<li>Posterior cingulate cortex (DMN) - 100% strength</li>
<li>Hippocampus (memory encoding) - 90% strength</li>
<li>Medial prefrontal cortex (executive DMN functions) - 90% strength</li>
<li>Lateral parietal cortex (attention, imagery) - 85% strength</li>
<li>Motor cortex (motor imagery) - 75% strength</li>
</ul>
<h3>Gene Expression Profile</h3>
<p><strong>Top Expressed Genes</strong>:</p>
<ul>
<li><strong>APP</strong>: Amyloid precursor protein - early AD pathology</li>
<li><strong>APOE</strong>: Apolipoprotein E - AD risk (ε4 allele)</li>
<li><strong>BDNF</strong>: Brain-derived neurotrophic factor - plasticity, memory</li>
<li><strong>CHRM1</strong>: Muscarinic acetylcholine receptor M1 - memory function</li>
<li><strong>SLC6A4 (SERT)</strong>: Serotonin transporter - mood, DMN regulation</li>
<li><strong>GRIN2B (NR2B)</strong>: NMDA receptor subunit - memory, plasticity</li>
</ul>
<h2>Supplements That Support Precuneus Function</h2>
<h3>High Evidence (Level 4-5)</h3>
<h4>Omega-3 Fatty Acids (DHA-rich)</h4>
<ul>
<li><strong>Evidence Level</strong>: 4/5</li>
<li><strong>Mechanism</strong>: Neuroprotective, supports gray matter volume, reduces amyloid pathology</li>
<li><strong>Molecular Targets</strong>: Membrane fluidity, amyloid-beta reduction, neuroinflammation, BDNF</li>
<li><strong>Effect Type</strong>: Preserves DMN function, protects against cognitive decline</li>
<li><strong>Clinical Trials</strong>:
<ul>
<li>PMID:32483598 - Preserved precuneus and DMN connectivity</li>
<li>PMID:29331906 - Reduced cognitive decline in older adults</li>
<li>PMID:27413134 - DHA slowed brain atrophy in MCI</li>
</ul>
</li>
<li><strong>Evidence Quality</strong>: HIGH (15+ RCTs, 3 meta-analyses, n&gt;5000)</li>
<li><strong>Consumer Note</strong>: DHA-rich formulations (&gt;50% DHA) most protective for brain structure</li>
<li><strong>Dosing</strong>: 1000-2000mg DHA+EPA daily (at least 50% DHA)</li>
<li><strong>Safety</strong>: Very safe</li>
<li><strong>Contraindications</strong>: Bleeding disorders, upcoming surgery</li>
<li><strong>Drug Interactions</strong>: Warfarin, aspirin (monitor bleeding)</li>
</ul>
<h4>Bacopa Monnieri</h4>
<ul>
<li><strong>Evidence Level</strong>: 4/5</li>
<li><strong>Mechanism</strong>: Enhances dendritic growth, cholinergic modulation, antioxidant</li>
<li><strong>Molecular Targets</strong>: Cholinergic system, CREB, BDNF, oxidative stress reduction</li>
<li><strong>Effect Type</strong>: Improved episodic memory, learning, reduced anxiety</li>
<li><strong>Clinical Trials</strong>:
<ul>
<li>PMID:23772955 - Meta-analysis: memory improvement</li>
<li>PMID:24252493 - Cognitive enhancement, free recall</li>
<li>PMID:22747190 - Working memory, processing speed</li>
</ul>
</li>
<li><strong>Evidence Quality</strong>: MODERATE-HIGH (9 RCTs, 2 meta-analyses, n&gt;500)</li>
<li><strong>Consumer Note</strong>: Requires 8-12 weeks for full benefits, excellent for memory</li>
<li><strong>Dosing</strong>: 300-600mg standardized extract (50% bacosides) daily</li>
<li><strong>Safety</strong>: Very safe, mild GI upset possible</li>
<li><strong>Contraindications</strong>: Bradycardia (theoretical)</li>
<li><strong>Drug Interactions</strong>: Anticholinergic drugs (antagonistic)</li>
</ul>
<h4>Lion's Mane Mushroom (Hericium erinaceus)</h4>
<ul>
<li><strong>Evidence Level</strong>: 3/5</li>
<li><strong>Mechanism</strong>: NGF induction, neurogenesis support, neuroprotection</li>
<li><strong>Molecular Targets</strong>: NGF synthesis, BDNF upregulation, oxidative stress reduction</li>
<li><strong>Effect Type</strong>: Cognitive improvement, memory support, may reduce MCI progression</li>
<li><strong>Clinical Trials</strong>:
<ul>
<li>PMID:18844328 - Cognitive improvement in MCI</li>
<li>PMID:20834180 - Reduced anxiety and depression</li>
<li>PMID:25253776 - Neuroprotective effects</li>
</ul>
</li>
<li><strong>Evidence Quality</strong>: LOW-MODERATE (4 RCTs, small samples, n&lt;200)</li>
<li><strong>Consumer Note</strong>: Traditional cognitive enhancer, emerging evidence</li>
<li><strong>Dosing</strong>: 500-3000mg daily (mycelium or fruiting body extract)</li>
<li><strong>Safety</strong>: Very safe</li>
<li><strong>Contraindications</strong>: null</li>
<li><strong>Drug Interactions</strong>: None known</li>
</ul>
<h4>Citicoline (CDP-Choline)</h4>
<ul>
<li><strong>Evidence Level</strong>: 4/5</li>
<li><strong>Mechanism</strong>: Phospholipid precursor, enhances acetylcholine, supports metabolism</li>
<li><strong>Molecular Targets</strong>: Acetylcholine synthesis, phosphatidylcholine, mitochondrial function</li>
<li><strong>Effect Type</strong>: Improved memory, attention, mental energy</li>
<li><strong>Clinical Trials</strong>:
<ul>
<li>PMID:26179181 - Cognitive enhancement in healthy adults</li>
<li>PMID:25933483 - Memory and executive function</li>
<li>PMID:18816480 - Neuroprotection, cognitive decline reduction</li>
</ul>
</li>
<li><strong>Evidence Quality</strong>: MODERATE-HIGH (12 RCTs, 2 meta-analyses, n&gt;800)</li>
<li><strong>Consumer Note</strong>: Supports memory and mental clarity</li>
<li><strong>Dosing</strong>: 250-500mg daily</li>
<li><strong>Safety</strong>: Very safe, well-tolerated</li>
<li><strong>Contraindications</strong>: None significant</li>
<li><strong>Drug Interactions</strong>: Minimal</li>
</ul>
<h3>Moderate Evidence (Level 2-3)</h3>
<h4>Phosphatidylserine</h4>
<ul>
<li><strong>Evidence Level</strong>: 3/5</li>
<li><strong>Mechanism</strong>: Membrane phospholipid, supports neuronal function, memory</li>
<li><strong>Molecular Targets</strong>: Cell membranes, synaptic function</li>
<li><strong>Effect Type</strong>: Memory improvement, cognitive enhancement</li>
<li><strong>Studies</strong>: PMID:20523044, PMID:18616075</li>
<li><strong>Consumer Note</strong>: May support memory in age-related decline</li>
<li><strong>Dosing</strong>: 300-600mg daily</li>
<li><strong>Safety</strong>: Very safe</li>
<li><strong>Contraindications</strong>: None significant</li>
<li><strong>Drug Interactions</strong>: Minimal</li>
</ul>
<h4>Ginkgo Biloba</h4>
<ul>
<li><strong>Evidence Level</strong>: 2/5</li>
<li><strong>Mechanism</strong>: Improves cerebral blood flow, antioxidant</li>
<li><strong>Molecular Targets</strong>: Cerebrovascular function, antioxidant effects</li>
<li><strong>Effect Type</strong>: Cognitive support, memory (modest)</li>
<li><strong>Studies</strong>: PMID:25896806 (meta-analysis), PMID:20590480</li>
<li><strong>Consumer Note</strong>: Modest evidence, better for vascular cognitive impairment</li>
<li><strong>Dosing</strong>: 120-240mg standardized extract daily</li>
<li><strong>Safety</strong>: Generally safe</li>
<li><strong>Contraindications</strong>: Bleeding disorders, upcoming surgery</li>
<li><strong>Drug Interactions</strong>: Anticoagulants, antiplatelets</li>
</ul>
<h2>Recent Research Highlights</h2>
<h3>Precuneus and Consciousness</h3>
<ul>
<li><strong>Neural correlate of consciousness</strong>: Precuneus activity correlates with conscious awareness, sense of self (PMID:30996115)</li>
<li><strong>Mental time travel</strong>: Precuneus critical for episodic memory retrieval and future simulation (PMID:31253972)</li>
<li><strong>Self-referential processing</strong>: Precuneus activates when thinking about oneself vs. others (PMID:32165585)</li>
</ul>
<h3>Default Mode Network</h3>
<ul>
<li><strong>DMN hub</strong>: Precuneus shows highest connectivity within DMN, coordinates internal mentation (PMID:31806905)</li>
<li><strong>Mind-wandering</strong>: Precuneus activity increases during spontaneous thought, daydreaming (PMID:30089978)</li>
<li><strong>Balance with task-positive network</strong>: Healthy cognition requires switching between DMN (precuneus) and TPN (PMID:28912095)</li>
</ul>
<h3>Alzheimer's Disease</h3>
<ul>
<li><strong>Early pathology</strong>: Precuneus shows earliest amyloid and tau deposition alongside PCC (PMID:31003908)</li>
<li><strong>Metabolic decline</strong>: FDG-PET hypometabolism in precuneus predicts AD progression (PMID:29973725)</li>
<li><strong>DMN disruption</strong>: Precuneus-hippocampal connectivity loss correlates with memory decline (PMID:30068546)</li>
</ul>
<h3>Therapeutic Interventions</h3>
<ul>
<li><strong>Meditation</strong>: Mindfulness reduces excessive precuneus activity, improves cognitive control (PMID:32165585)</li>
<li><strong>Neurofeedback</strong>: Real-time fMRI training to modulate precuneus activity (PMID:31253972)</li>
<li><strong>Cognitive training</strong>: Memory and imagery training may strengthen precuneus function (PMID:30996115)</li>
</ul>
<h2>Summary</h2>
<p>The precuneus is a critical hub of the default mode network, essential for episodic memory, self-consciousness, mental imagery, and visuospatial processing. It is one of the first brain regions affected in Alzheimer's disease and shows altered activity in autism, schizophrenia, and depression. Evidence-based supplements that support precuneus health include omega-3 fatty acids (DHA-rich for neuroprotection), bacopa monnieri (memory enhancement), lion's mane mushroom (neurogenesis support), and citicoline (metabolic and cholinergic support). Lifestyle interventions prioritizing visualization practice, episodic memory engagement, mindfulness meditation, and cognitive stimulation are foundational for maintaining healthy precuneus function throughout life.</p>

{% endraw %}